AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 5th, 2023 • Acrivon Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledJune 5th, 2023 Company Industry JurisdictionThis Amended and Restated Executive Employment Agreement (this “Agreement”), is entered into this 30th day of May, 2023, and is by and between Acrivon Therapeutics Inc., a Delaware corporation (“Company”), and Kristina M. Masson (“Executive”), and made effective as of June 1, 2023 (the “A&R Effective Date”).
EMPLOYMENT CONTRACT On this day this the following contract of employment (“the Agreement”) has been entered into between andEmployment Contract • June 5th, 2023 • Acrivon Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJune 5th, 2023 Company IndustryAcrivon AB hereinafter referred to as (”Employer”). Kristina Masson, hereinafter referred to as (“Employee”). The Employer and the Employee are collectively referred to as (“the Parties”) and separately as (“Party”).